Cogentix Medical (NASDAQ:CGNT) Rating Increased to C at TheStreet

Cogentix Medical (NASDAQ:CGNT) was upgraded by stock analysts at TheStreet from a “d+” rating to a “c” rating in a research note issued to investors on Thursday, November 9th.

Several other analysts have also issued reports on the company. Roth Capital assumed coverage on Cogentix Medical in a report on Wednesday, November 8th. They set a “buy” rating and a $4.00 target price on the stock. JMP Securities assumed coverage on Cogentix Medical in a report on Friday, October 6th. They set an “outperform” rating and a $5.00 target price on the stock. Finally, Zacks Investment Research lowered Cogentix Medical from a “buy” rating to a “hold” rating in a report on Tuesday, October 3rd.

Cogentix Medical (NASDAQ CGNT) traded down $0.12 during mid-day trading on Thursday, hitting $2.73. The stock had a trading volume of 369,682 shares, compared to its average volume of 62,193. Cogentix Medical has a 52 week low of $1.55 and a 52 week high of $3.26.

Large investors have recently added to or reduced their stakes in the business. Northern Trust Corp raised its stake in Cogentix Medical by 0.4% in the second quarter. Northern Trust Corp now owns 73,926 shares of the medical device company’s stock valued at $129,000 after buying an additional 326 shares during the period. Dimensional Fund Advisors LP bought a new stake in Cogentix Medical in the third quarter valued at approximately $152,000. Renaissance Technologies LLC raised its stake in Cogentix Medical by 2.3% in the first quarter. Renaissance Technologies LLC now owns 562,996 shares of the medical device company’s stock valued at $1,013,000 after buying an additional 12,459 shares during the period. Finally, Broadfin Capital LLC raised its stake in Cogentix Medical by 45.2% in the second quarter. Broadfin Capital LLC now owns 1,094,544 shares of the medical device company’s stock valued at $1,905,000 after buying an additional 340,771 shares during the period. Hedge funds and other institutional investors own 13.33% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This article was reported by BBNS and is the property of of BBNS. If you are reading this article on another domain, it was copied illegally and republished in violation of United States and international trademark and copyright law. The correct version of this article can be read at https://baseballnewssource.com/markets/cogentix-medical-inc-cgnt-upgraded-by-thestreet-to-c/1769322.html.

Cogentix Medical Company Profile

Cogentix Medical, Inc is a global medical device company. The Company designs, develops, manufactures and markets a line of fiber-optic and video endoscopy products under the PrimeSight brand that are used across various surgical specialties in diagnostic and treatment procedures. The Company also offers the Urgent PC Neuromodulation System (Urgent PC Systems), a device that delivers percutaneous tibial nerve stimulation (PTNS), for the office-based treatment of overactive bladder (OAB).

Receive News & Ratings for Cogentix Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cogentix Medical Inc. and related companies with our FREE daily email newsletter.

 


Latest News

Jack Morris, Alan Trammel Voted by Modern Era Committee into Hall of Fame
Jack Morris, Alan Trammel Voted by Modern Era Committee into Hall of Fame
Yankees and Marlins Continue Stanton Trade Talks
Yankees and Marlins Continue Stanton Trade Talks
Marlins Making Moves, Trade Dee Gordon to Seattle
Marlins Making Moves, Trade Dee Gordon to Seattle
Report: Astros Dallas Keuchel Pitched With Injured Foot
Report: Astros Dallas Keuchel Pitched With Injured Foot
Angels Sign Former Prospect with Braves Kevin Maitan
Angels Sign Former Prospect with Braves Kevin Maitan
Shohei Ohtani Has Turned Down Red Sox and Yankees
Shohei Ohtani Has Turned Down Red Sox and Yankees


Leave a Reply

 
© 2006-2017 BBNS.